All In Biotech

Drug Trial Radar · NCT06706674

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Lumateperone in the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients 5 to 17 Years of Age

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Dec 6, 2024

Primary completion

Jun 21, 2027

Study completion Jun 21, 2027

Sponsor

Lead sponsor
Intra-Cellular Therapies, Inc.Industry
Sponsor type
Industry
First posted
Nov 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 5 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability associated with Autism Spectrum Disorder (ASD) based on Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Text Revision (DSM-5-TR) and confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version (K-SADS-PL).

Conditions

  • Irritability Associated With Autism Spectrum Disorder

Interventions

  • Lumateperone high doseDrug

    Lumateperone administered orally once daily

  • Lumateperone low doseDrug

    Lumateperone administered orally once daily

  • PlaceboDrug

    Matching Placebo administered orally once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Aberrant Behavior Checklist - Irritability (ABC-I)Time frame: Week 6

Locations

41 sites in 1 country. Site status is shown where the registry gives one.

  • Pillar Clinical Research, LLC

    Little Rock, Arkansas · Recruiting

  • University Of California - Davis

    Sacramento, California · Recruiting

  • California Neuroscience Research

    Sherman Oaks, California · Recruiting

  • Yale University School Of Medicine

    New Haven, Connecticut · Recruiting

  • United Research Institute

    Hialeah, Florida · Recruiting

  • Advanced Research Institute of Miami

    Homestead, Florida · Suspended

  • Vital Care Research

    Miami, Florida · Suspended

  • Care Research Center Inc

    Miami, Florida · Recruiting

  • Blue Medical Research

    Miami, Florida · Recruiting

  • AP Medical Research

    Miami, Florida · Recruiting

  • GTL Medical and Research Group

    Miami, Florida · Completed

  • New Med Research Inc

    Miami Gardens, Florida · Recruiting

  • Riveldi Biomedical Research

    Miami Lakes, Florida · Suspended

  • APG Research LLC

    Orlando, Florida · Recruiting

  • Orlando Psychiatric Associates

    Orlando, Florida · Completed

  • Clinical Research Center of Florida

    Pompano Beach, Florida · Recruiting

  • University of South Florida Rothman Center of Neuropsychiatry

    St. Petersburg, Florida · Recruiting

  • Advanced Discovery Research

    Atlanta, Georgia · Completed

  • Salveo Integrative Health Inc

    Lawrenceville, Georgia · Completed

  • EmVenio Research at Chicago

    Chicago, Illinois · Recruiting

  • Baber Research Group

    Naperville, Illinois · Recruiting

  • Riley Hospital for Children at Indiana University Health

    Indianapolis, Indiana · Completed

  • Louisiana State University Health Sciences Center Shreveport

    Shreveport, Louisiana · Recruiting

  • Neurobehavioral Medicine Group

    Bloomfield Hills, Michigan · Recruiting

  • Alivation Research LLC

    Lincoln, Nebraska · Recruiting

  • NYU Child Study Center

    New York, New York · Suspended

  • Nathan Kline Institute

    Orangeburg, New York · Recruiting

  • Richmond Behavioral Associates

    Staten Island, New York · Recruiting

  • Albert Einstein College Of Medicine

    The Bronx, New York · Recruiting

  • Advantage Clinical Trials

    The Bronx, New York · Recruiting

  • Quest Therapeutics of Avon Lake

    Avon Lake, Ohio · Completed

  • Sooner Clinical Research

    Norman, Oklahoma · Recruiting

  • SP Research, PLLC (dba Rivus Wellness & Research Institute)

    Oklahoma City, Oklahoma · Recruiting

  • Medical University of South Carolina

    Charleston, South Carolina · Recruiting

  • BioBehavioral Research of Austin PC

    Austin, Texas · Completed

  • Texas Research Group

    Coppell, Texas · Recruiting

  • Future Search Trials of Dallas

    Dallas, Texas · Completed

  • North Texas Clinical Trials

    Fort Worth, Texas · Recruiting

  • Red Oak Psychiatry Associates

    Houston, Texas · Completed

  • Virginia Commonwealth University

    Richmond, Virginia · Recruiting

Showing 40 of 41 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.